Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Science and Technology Venture Capital (Group), commonly known as Shanghai STVC, is a leading state-owned venture capital firm headquartered in Shanghai, China. The firm serves as a strategic investment platform for the Shanghai municipal government, focusing on high-tech industries such as biopharmaceuticals, integrated circuits, and new materials. In the healthcare and life sciences sector, Shanghai STVC provides early-stage and growth-stage funding to innovative companies involved in drug discovery, medical devices, and diagnostics. The group has been instrumental in the development of the Shanghai Science and Technology Innovation Center, managing several large-scale funds that support the entire lifecycle of technology-driven enterprises. Notable biotech companies in its portfolio have successfully reached clinical milestones and public listings on global exchanges.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Science and Technology Venture Capital (Group).